Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
21 01 2020
Historique:
received: 07 02 2019
accepted: 20 10 2019
revised: 02 10 2019
entrez: 19 2 2020
pubmed: 19 2 2020
medline: 22 6 2021
Statut: epublish

Résumé

Converging evidence indicates that orexins (ORXs), the regulatory neuropeptides, are implicated in anxiety- and depression-related behaviors via the modulation of neuroendocrine, serotonergic, and noradrenergic systems. This study evaluated the role of the orexinergic system in stress-associated physiological responses in a controlled prospective animal model. The pattern and time course of activation of hypothalamic ORX neurons in response to predator-scent stress (PSS) were examined using c-Fos as a marker for neuronal activity. The relationship between the behavioral response pattern 7 days post-exposure and expressions of ORXs was evaluated. We also investigated the effects of intracerebroventricular microinfusion of ORX-A or almorexant (ORX-A/B receptor antagonist) on behavioral responses 7 days following PSS exposure. Hypothalamic levels of ORX-A, neuropeptide Y (NPY), and brain-derived neurotrophic factor (BDNF) were assessed. Compared with rats whose behaviors were extremely disrupted (post-traumatic stress disorder [PTSD]-phenotype), those whose behaviors were minimally selectively disrupted displayed significantly upregulated ORX-A and ORX-B levels in the hypothalamic nuclei. Intracerebroventricular microinfusion of ORX-A before PSS reduced the prevalence of the PTSD phenotype compared with that of artificial cerebrospinal fluid or almorexant, and rats treated with almorexant displayed a higher prevalence of the PTSD phenotype than did untreated rats. Activated ORX neurons led to upregulated expressions of BDNF and NPY, which might provide an additional regulatory mechanism for the modulation of adaptive stress responses. The study indicates that the activated ORX system might promote adaptive responses to PSS probably via stimulation of BDNF and NPY secretion, and early intervention with ORX-A reduces the prevalence of the PTSD phenotype and increases the prevalence of adaptive phenotypes. The findings provide some insights into the mechanisms underlying the involvement of the ORX system in stress-related disorders.

Identifiants

pubmed: 32066707
doi: 10.1038/s41398-020-0698-9
pii: 10.1038/s41398-020-0698-9
pmc: PMC7026175
doi:

Substances chimiques

Neuropeptide Y 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10

Références

Neuropeptides. 2007 Jun;41(3):117-33
pubmed: 17376528
J Neurosci Methods. 2011 Apr 15;197(1):21-31
pubmed: 21277897
Int J Neuropsychopharmacol. 2007 Dec;10(6):741-58
pubmed: 17291374
Regul Pept. 2002 Mar 15;104(1-3):97-103
pubmed: 11830283
Biol Psychiatry. 2003 Mar 15;53(6):463-73
pubmed: 12644351
Psychol Med. 2011 Apr;41(4):699-707
pubmed: 21108868
Pharmacol Biochem Behav. 2010 Mar;95(1):121-8
pubmed: 20045021
Curr Top Behav Neurosci. 2015;25:367-78
pubmed: 25502546
Trends Neurosci. 2015 Sep;38(9):550-9
pubmed: 26216377
Regul Pept. 2004 Mar 15;117(3):155-8
pubmed: 14749034
J Clin Endocrinol Metab. 2001 Feb;86(2):778-82
pubmed: 11158046
Nature. 2005 Sep 22;437(7058):556-9
pubmed: 16100511
Front Pharmacol. 2014 Feb 12;5:16
pubmed: 24575043
Neuropeptides. 2002 Apr-Jun;36(2-3):85-95
pubmed: 12359500
Biol Psychiatry. 2008 Oct 15;64(8):708-17
pubmed: 18635156
Curr Protoc Neurosci. 2013 Jul;Chapter 9:Unit 9.45
pubmed: 23853112
Neurosci Lett. 2009 Jan 30;450(2):132-5
pubmed: 19026718
Nat Rev Neurosci. 2002 May;3(5):339-49
pubmed: 11988773
Exp Neurol. 2016 Oct;284(Pt B):133-140
pubmed: 27481726
Mol Neurobiol. 2005 Dec;32(3):285-94
pubmed: 16385142
Neuropsychopharmacology. 2004 Nov;29(11):1962-70
pubmed: 15257304
Pharmacol Rev. 2006 Mar;58(1):46-57
pubmed: 16507882
Physiol Behav. 2011 Oct 24;104(5):823-30
pubmed: 21839102
Am J Psychiatry. 2015 Dec;172(12):1242-50
pubmed: 26206076
J Neurosci. 2004 Dec 15;24(50):11439-48
pubmed: 15601950
Nat Neurosci. 2014 Oct;17(10):1298-303
pubmed: 25254979
Endocrinology. 1999 Dec;140(12):5991-4
pubmed: 10579367
Psychol Med. 2016 Sep;46(12):2627-36
pubmed: 27377418
Am J Psychiatry. 2015 Dec;172(12):1233-41
pubmed: 26206075
Neuroscience. 2015 Aug 6;300:370-80
pubmed: 26022361
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
pubmed: 9419374
Psychoneuroendocrinology. 2010 Aug;35(7):1001-7
pubmed: 20116928
Biol Psychiatry. 2005 Oct 15;58(8):640-50
pubmed: 15978551
J Physiol. 2009 Jan 15;587(1):33-40
pubmed: 19047201
Acta Physiol (Oxf). 2010 Mar;198(3):251-62
pubmed: 19785627
Neuroreport. 2000 Jun 26;11(9):1977-80
pubmed: 10884055
Transl Psychiatry. 2016 Oct 11;6(10):e917
pubmed: 27727245
Neuropsychopharmacology. 2012 Jan;37(2):350-63
pubmed: 21976046
Biol Psychiatry. 2006 Jun 15;59(12):1208-18
pubmed: 16458266
Cell. 1998 Feb 20;92(4):573-85
pubmed: 9491897
J Anxiety Disord. 2011 Dec;25(8):1008-18
pubmed: 21782385
Neuropharmacology. 2017 Oct;125:129-145
pubmed: 28705440
Cell Metab. 2005 Apr;1(4):279-86
pubmed: 16054072
J Anxiety Disord. 2014 Mar;28(2):203-10
pubmed: 24291395
J Appl Physiol (1985). 2013 Oct 1;115(7):954-71
pubmed: 23640599
J Neurosci Methods. 1989 Sep;29(3):261-5
pubmed: 2507830
Neuron. 2003 Jun 5;38(5):701-13
pubmed: 12797956
Eur Neuropsychopharmacol. 2007 Sep;17(9):573-9
pubmed: 17346943
J Trauma Stress. 2014 Apr;27(2):232-239
pubmed: 24604631
Eur Neuropsychopharmacol. 2011 Nov;21(11):796-809
pubmed: 21741804
J Neurosci. 1998 Dec 1;18(23):9996-10015
pubmed: 9822755
Nat Commun. 2013;4:1547
pubmed: 23462990
Curr Opin Neurobiol. 2014 Dec;29:103-8
pubmed: 25050887
Int J Mol Med. 2001 Apr;7(4):401-4
pubmed: 11254881
Neuroscience. 2008 Dec 10;157(4):720-32
pubmed: 18952152
Prog Brain Res. 2012;198:133-61
pubmed: 22813973
Depress Anxiety. 2011 May;28(5):406-11
pubmed: 21381159
Eur J Neurosci. 2009 Oct;30(8):1603-14
pubmed: 19811530

Auteurs

Shlomi Cohen (S)

Ministry of Health, Beer-Sheva Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer- Sheva, Israel.
Department of Psychology, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Michael A Matar (MA)

Ministry of Health, Beer-Sheva Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer- Sheva, Israel.

Ella Vainer (E)

Ministry of Health, Beer-Sheva Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer- Sheva, Israel.

Joseph Zohar (J)

Division of Psychiatry, The Chaim Sheba Medical Center, Ramat-Gan, Israel.
Sackler Medical School, Tel-Aviv University, Tel-Aviv, Israel.

Zeev Kaplan (Z)

Ministry of Health, Beer-Sheva Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer- Sheva, Israel.

Hagit Cohen (H)

Ministry of Health, Beer-Sheva Mental Health Center, Anxiety and Stress Research Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer- Sheva, Israel. hagitc@bgu.ac.il.
Department of Psychology, Ben-Gurion University of the Negev, Beer-Sheva, Israel. hagitc@bgu.ac.il.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH